{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:13:04Z","timestamp":1778595184000,"version":"3.51.4"},"reference-count":34,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ThoracResPract"],"DOI":"10.4274\/thoracrespract.2026.2025-10-2","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:24:41Z","timestamp":1774333481000},"source":"Crossref","is-referenced-by-count":0,"title":["Cost Analysis of Tuberculosis Disease in the Case of Tuberculosis Control Dispensary"],"prefix":"10.4274","author":[{"given":"Dolunay \u00d6zlem","family":"Zeybek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Zeybek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130skender","family":"\u00c7etint\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"\u00d6zyi\u011fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"ref0","unstructured":"1. World World Health Organization. Global Tuberculosis Report 2023. Accessed February 26, 2026. [Crossref]"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One. 2011;6(4):17601. [Crossref]","DOI":"10.1371\/journal.pone.0017601"},{"key":"ref2","unstructured":"3. T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc. T\u00fcrkiye'de Verem Sava\u015f\u0131 2021 Raporu (T\u00fcrkiye Tuberculosis Control Report 2021) [Internet]. Ankara: T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131; 2023. Accessed February 26, 2026. [Crossref]"},{"key":"ref3","unstructured":"4. World Health Organization (WHO). The end TB strategy: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: WHO; 2014. [Crossref]"},{"key":"ref4","unstructured":"5. T\u00fcrkiye Ulusal Verem Sava\u015f Dernekleri Federasyonu. \u00dclkemizde veremle sava\u015f \u00e7al\u0131\u015fmalar\u0131 1918 y\u0131l\u0131nda Prof. Dr. Besim \u00d6mer (Akal\u0131n) Pa\u015fa'n\u0131n \"Veremle M\u00fccadele Osmanl\u0131 Cemiyeti\"ni kurmas\u0131yla ba\u015flam\u0131\u015ft\u0131r (The tuberculosis control activities in Turkey started in 1918 with the establishment of the \"Ottoman Society for Combating Tuberculosis\" by Prof. Dr. Besim \u00d6mer (Akal\u0131n) Pasha) [Internet]. Accessed February 26, 2026. [Crossref]"},{"key":"ref5","unstructured":"6. T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc. T\u00fcberk\u00fcloz Tan\u0131 ve Tedavi Rehberi (Tuberculosis Diagnosis and Treatment Guideline) [Internet]. Ankara: T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131; 2019. Accessed February 26, 2026. [Crossref]"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Assefa DG, Dememew ZG, Zeleke ED, et al. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):260. [Crossref]","DOI":"10.1186\/s12889-024-17713-9"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Burki TK. The global cost of tuberculosis. Lancet Respir Med. 2018;6(1):13. [Crossref]","DOI":"10.1016\/S2213-2600(17)30468-X"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Winston CA, Marks SM, Carr W. Estimated costs of 4-month pulmonary tuberculosis treatment regimen, United States. Emerg Infect Dis. 2023;29(10):2102-2104. [Crossref]","DOI":"10.3201\/eid2910.230314"},{"key":"ref9","unstructured":"10. T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc. Ek T\u00fcberk\u00fcloz Hastalar\u0131na Y\u00f6nelik \u015eartl\u0131 ve D\u00fczenli Nakdi Sosyal Yard\u0131m K\u0131lavuzu (Supplement: Conditional and Regular Cash Social Assistance Guide for Tuberculosis Patients) [Internet]. Ankara: T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131; 2023. Accessed February 26, 2026. [Crossref]"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Ghazy RM, El Saeh HM, Abdulaziz S, et al. A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients. Sci Rep. 2022;12(1):558. [Crossref]","DOI":"10.1038\/s41598-021-04345-x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Prasanna T, Jeyashree K, Chinnakali P, Bahurupi Y, Vasudevan K, Das M. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India. Glob Health Action. 2018;11(1):1477493. [Crossref]","DOI":"10.1080\/16549716.2018.1477493"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Oh P, Pascopella L, Barry PM, Flood JM. A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015. BMC Res Notes. 2017;10(1):434. [Crossref]","DOI":"10.1186\/s13104-017-2754-y"},{"key":"ref13","unstructured":"14. Sosyal G\u00fcvenlik Kurumu (SGK). 19\/10\/2023 SUT De\u011fi\u015fiklik Tebli\u011fi \u0130\u015flenmi\u015f G\u00fcncel 2013 SUT [Health Implementation Communiqu\u00e9 Amendment Notice]. Ankara: SGK; 2023. Accessed March 03, 2026. [Crossref]"},{"key":"ref14","unstructured":"15. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford: Oxford University Press. [Crossref]"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Rice DP. Cost of illness studies: what is good about them? Inj Prev. 2000;6(3):177-179. [Crossref]","DOI":"10.1136\/ip.6.3.177"},{"key":"ref16","unstructured":"17. T.C. Resm\u00ee Gazete (Official Gazette of the Republic of T\u00fcrkiye). 30.12.2023 tarihli say\u0131. Accessed March 03, 2026. [Crossref]"},{"key":"ref17","unstructured":"18. World Health Organization. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022. Accessed March 03, 2026. [Crossref]"},{"key":"ref18","unstructured":"19. T\u00fcrkiye Cumhuriyet Merkez Bankas\u0131 (Central Bank of the Republic of Turkey, CBRT). Daily exchange rates dated 01 September 2023. Accessed March 03, 2026. [Crossref]"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Jesus GS, Pescarini JM, Silva AF, et al. The effect of primary health care on tuberculosis in a nationwide cohort of 7.3 million Brazilian people: a quasi-experimental study. Lancet Glob Health. 2022;10(3):390-397. [Crossref]","DOI":"10.1016\/S2214-109X(21)00550-7"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Capeding TPJ, Rosa JD, Lam H, et al. Cost of TB prevention and treatment in the Philippines in 2017. Int J Tuberc Lung Dis. 2022;26(5):392-398. [Crossref]","DOI":"10.5588\/ijtld.21.0622"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Budgell EP, Evans D, Leuner R, Long L, Rosen S. The costs and outcomes of paediatric tuberculosis treatment at primary healthcare clinics in Johannesburg, South Africa. S Afr Med J. 2018;108(5):423-431. [Crossref]","DOI":"10.7196\/SAMJ.2018.v108i5.12802"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Kamchedzera W, Maheswaran H, Squire SB, et al. Economic costs of accessing tuberculosis (TB) diagnostic services in Malawi: an analysis of patient costs from a randomised controlled trial of computer-aided chest X-ray interpretation. Wellcome Open Res. 2021;6:153. [Crossref]","DOI":"10.12688\/wellcomeopenres.16683.1"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Chandra A, Kumar R, Kant S, Parthasarathy R, Krishnan A. Direct and indirect patient costs of tuberculosis care in India. Trop Med Int Health. 2020;25(7):803-812. [Crossref]","DOI":"10.1111\/tmi.13402"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Portnoy A, Yamanaka T, Nguhiu P, et al. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis. Lancet Glob Health. 2023;11:1640-1647. [Crossref]","DOI":"10.1016\/S2214-109X(23)00369-8"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Tanimura T, Jaramillo E, Weil D, Raviglione M, L\u00f6nnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1675-1763. [Crossref]","DOI":"10.1183\/09031936.00193413"},{"key":"ref26","unstructured":"27. John KR, Daley P, Kincler N, Oxlade O, Menzies D. Costs incurred by patients with pulmonary tuberculosis in rural India. Int J Tuberc Lung Dis. 2009;13(10):1281-1287. [Crossref]"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Razzaq S, Zahidie A, Fatmi Z. Estimating the pre- and post-diagnosis costs of tuberculosis for adults in Pakistan: household economic impact and costs mitigating strategies. Glob Health Res Policy. 2022;7(1):22. [Crossref]","DOI":"10.1186\/s41256-022-00259-x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Xia L, Gao L, Zhong Y, et al. Assessing the influencing factors of out-of-pocket costs on tuberculosis in Sichuan Province: a cross-sectional study. BMC Public Health. 2023;23:1391. [Crossref]","DOI":"10.1186\/s12889-023-16180-y"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Asres A, Jerene D, Deressa W. Pre- and post-diagnosis costs of tuberculosis to patients on directly observed treatment short course in districts of southwestern Ethiopia: a longitudinal study. J Health Popul Nutr. 2018;37(1):15. [Crossref]","DOI":"10.1186\/s41043-018-0146-0"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Pichenda K, Nakamura K, Morita A, Kizuki M, Seino K, Takano T. Non-hospital DOT and early diagnosis of tuberculosis reduce costs while achieving treatment success. Int J Tuberc Lung Dis. 2012;16(6):828-834. [Crossref]","DOI":"10.5588\/ijtld.11.0688"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Mauch V, Melgen R, Marcelino B, Acosta I, Klinkenberg E, Suarez P. Tuberculosis patients in the Dominican Republic face severe direct and indirect costs and need social protection. Rev Panam Salud Publica. 2013;33(5):332-339. [Crossref]","DOI":"10.1590\/S1020-49892013000500004"},{"key":"ref32","unstructured":"33. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis. 2003;7(Suppl 1):29-37. [Crossref]"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Gull\u00f3n JA, Garc\u00eda-Garc\u00eda JM, Villanueva M\u00c1, et al. Tuberculosis costs in Spain and related factors. Arch Bronconeumol. 2016;52(12):583-589. [Crossref]","DOI":"10.1016\/j.arbr.2016.05.015"}],"container-title":["Thoracic Research and Practice"],"original-title":[],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:07:50Z","timestamp":1778591270000},"score":1,"resource":{"primary":{"URL":"https:\/\/thoracrespract.org\/articles\/cost-analysis-of-tuberculosis-disease-in-the-case-of-tuberculosis-control-dispensary\/doi\/ThoracResPract.2026.2025-10-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":34,"URL":"https:\/\/doi.org\/10.4274\/thoracrespract.2026.2025-10-2","relation":{},"ISSN":["2979-9139"],"issn-type":[{"value":"2979-9139","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}